Published in Surg Oncol Clin N Am on July 01, 2009
The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol (2012) 1.60
Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol (2015) 0.98
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol (2015) 0.86
Obesity and cholangiocarcinoma. World J Gastroenterol (2013) 0.81
Risk factors for neoplastic progression in Barrett's esophagus. World J Gastroenterol (2011) 0.77
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Colorectal cancer in African Americans. Am J Gastroenterol (2005) 3.18
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
An early experience using the technique of transoral OrVil EEA stapler for minimally invasive transthoracic esophagectomy. Ann Thorac Surg (2011) 1.99
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer (2005) 1.75
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol (2007) 1.63
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis (2013) 1.51
Factors that predict relief from upper abdominal pain after cholecystectomy. Clin Gastroenterol Hepatol (2011) 1.50
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol (2011) 1.32
Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol (2008) 1.28
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25
Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol (2009) 1.21
Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol (2010) 1.15
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One (2008) 1.12
Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc (2008) 1.10
Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc (2010) 1.10
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia (2009) 1.06
Effect of Roux-en-Y gastric bypass in obese patients with Barrett's esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis (2007) 0.92
Supraesophageal reflux: validation of a symptom questionnaire. Otolaryngol Head Neck Surg (2006) 0.90
The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus (2009) 0.87
Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci (2011) 0.85
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 0.84
Impact of display alternatives in the determination of bolus handling: a study using high-resolution manometry with impedance. Am J Gastroenterol (2011) 0.82
Impact of feedback and didactic sessions on the reporting behavior of upper endoscopic findings by physicians and nurses. Clin Gastroenterol Hepatol (2007) 0.80
Eosinophilic esophagitis: its role in aerodigestive tract disorders. Otolaryngol Clin North Am (2006) 0.80
Prevalence of esophageal eosinophils in patients with Barrett's esophagus. Am J Gastroenterol (2011) 0.80
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci (2010) 0.80
Once-daily omeprazole/sodium bicarbonate heals severe refractory reflux esophagitis with morning or nighttime dosing. Dig Dis Sci (2014) 0.78
The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction. Gastroenterol Clin North Am (2009) 0.75
Image of the month. Verrucous squamous cell carcinoma: a rare esophageal malignancy. Clin Gastroenterol Hepatol (2009) 0.75
Barrett's esophagus: prevalence and incidence of adenocarcinomas. Ann N Y Acad Sci (2011) 0.75
Barrett's esophagus registries. Ann N Y Acad Sci (2011) 0.75
Adenocarcinoma of the esophagogastric junction may arise from short-segment Barrett's esophagus. Am J Gastroenterol (2008) 0.75